114 related articles for article (PubMed ID: 1318311)
41. 1,25 dihydroxyvitamin D3 enhances the calcium response of keratinocytes.
Ratnam AV; Bikle DD; Cho JK
J Cell Physiol; 1999 Feb; 178(2):188-96. PubMed ID: 10048583
[TBL] [Abstract][Full Text] [Related]
42. Phosphorylation of Human Retinoid X Receptor α at Serine 260 Impairs Its Subcellular Localization, Receptor Interaction, Nuclear Mobility, and 1α,25-Dihydroxyvitamin D3-dependent DNA Binding in Ras-transformed Keratinocytes.
Jusu S; Presley JF; Kremer R
J Biol Chem; 2017 Jan; 292(4):1490-1509. PubMed ID: 27852823
[TBL] [Abstract][Full Text] [Related]
43. 1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclones.
Taoka T; Collins ED; Irino S; Norman AW
Mol Cell Endocrinol; 1993 Sep; 95(1-2):51-7. PubMed ID: 8243807
[TBL] [Abstract][Full Text] [Related]
44. The mRNA expression of the human 1,25-dihydroxyvitamin D3 receptor and the c-myc protooncogene in cultured human keratinocytes.
Hanafin NM; Persons KS; Holick MF
In Vitro Cell Dev Biol Anim; 1994 Mar; 30A(3):187-91. PubMed ID: 25939167
[TBL] [Abstract][Full Text] [Related]
45. 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts.
Scharla SH; Strong DD; Mohan S; Baylink DJ; Linkhart TA
Endocrinology; 1991 Dec; 129(6):3139-46. PubMed ID: 1720089
[TBL] [Abstract][Full Text] [Related]
46. Demonstration and characterization of 1,25-dihydroxyvitamin D3 receptors in basal cells of epidermis of neonatal and adult mice.
Merke J; Schwittay D; Fürstenberger G; Gross M; Marks F; Ritz E
Calcif Tissue Int; 1985 May; 37(3):257-67. PubMed ID: 2990643
[TBL] [Abstract][Full Text] [Related]
47. 1,25-Dihydroxyvitamin D3 increases the growth-promoting activity of autocrine epidermal growth factor receptor ligands in keratinocytes.
Garach-Jehoshua O; Ravid A; Liberman UA; Koren R
Endocrinology; 1999 Feb; 140(2):713-21. PubMed ID: 9927298
[TBL] [Abstract][Full Text] [Related]
48. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
[TBL] [Abstract][Full Text] [Related]
49. Synchronization of normal human keratinocyte in culture: its application to the analysis of 1,25-dihydroxyvitamin D3 effects on cell cycle.
Kobayashi T; Okumura H; Hashimoto K; Asada H; Inui S; Yoshikawa K
J Dermatol Sci; 1998 Jun; 17(2):108-14. PubMed ID: 9673892
[TBL] [Abstract][Full Text] [Related]
50. 1,25-Dihydroxyvitamin D3 receptor RNA: expression in hematopoietic cells.
Kizaki M; Norman AW; Bishop JE; Lin CW; Karmakar A; Koeffler HP
Blood; 1991 Mar; 77(6):1238-47. PubMed ID: 1705836
[TBL] [Abstract][Full Text] [Related]
51. Enhancement by 1 alpha,25-dihydroxyvitamin D3 of chemically induced transformation of BALB 3T3 cells without induction of ornithine decarboxylase or activation of protein kinase C1.
Sasaki K; Chida K; Hashiba H; Kamata N; Abe E; Suda T; Kuroki T
Cancer Res; 1986 Feb; 46(2):604-10. PubMed ID: 3000580
[TBL] [Abstract][Full Text] [Related]
52. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
53. Growth inhibition of human keratinocytes by 1,25-dihydroxyvitamin D3 is linked to dephosphorylation of retinoblastoma gene product.
Kobayashi T; Hashimoto K; Yoshikawa K
Biochem Biophys Res Commun; 1993 Oct; 196(1):487-93. PubMed ID: 8216332
[TBL] [Abstract][Full Text] [Related]
54. 1,25-Dihydroxyvitamin D3 and the regulation of human cancer cell replication.
Eisman JA; Koga M; Sutherland RL; Barkla DH; Tutton PJ
Proc Soc Exp Biol Med; 1989 Jul; 191(3):221-6. PubMed ID: 2740355
[TBL] [Abstract][Full Text] [Related]
55. 1,25-dihydroxyvitamin D3 regulates estrogen metabolism in cultured keratinocytes.
Hughes SV; Robinson E; Bland R; Lewis HM; Stewart PM; Hewison M
Endocrinology; 1997 Sep; 138(9):3711-8. PubMed ID: 9275056
[TBL] [Abstract][Full Text] [Related]
56. Physiological effects of 1,25-dihydroxyvitamin D3 in TM4 Sertoli cell line.
Akerstrom VL; Walters MR
Am J Physiol; 1992 Jun; 262(6 Pt 1):E884-90. PubMed ID: 1319682
[TBL] [Abstract][Full Text] [Related]
57. 1 alpha,24R-dihydroxyvitamin D3 has an ability comparable to that of 1 alpha,25-dihydroxyvitamin D3 to induce keratinocyte differentiation.
Kobayashi T; Okumura H; Azuma Y; Kiyoki M; Matsumoto K; Hashimoto K; Yoshikawa K
J Dermatol; 1990 Nov; 17(11):707-9. PubMed ID: 2094749
[TBL] [Abstract][Full Text] [Related]
58. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
[TBL] [Abstract][Full Text] [Related]
59. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
Levy Y; Knutson JC; Bishop C; Shany S
Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
[TBL] [Abstract][Full Text] [Related]
60. 1,25-Dihydroxyvitamin D3 binds specifically to rat vascular smooth muscle cells and stimulates their proliferation in vitro.
Koh E; Morimoto S; Fukuo K; Itoh K; Hironaka T; Shiraishi T; Onishi T; Kumahara Y
Life Sci; 1988; 42(2):215-23. PubMed ID: 2826956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
